Advertisement
Reassurance from the lipid outcomes trial with the highest percentage female enrollment to date
Tech-assisted self-selection concurred with clinician-assessed eligibility in >90% of cases
Newly identified pathway may explain the so-called niacin paradox
It's time to increase testing for this major cardiovascular risk factor in advance of new therapies
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Findings establish overweight/obesity as a modifiable risk factor for cardiovascular disease
Undetectable levels achieved for nearly nine months in phase 1 trial
Observational study supports adding CAC score to traditional risk factors for precision medicine approach
Results inform dose selection for further trials of the aldosterone synthase inhibitor
Rates of CR eligibility high and internet access low among older patients in rural areas
Robust reductions in cardiac events seen in high-risk patients without prior events
Advertisement
Advertisement